Identification of Surface Markers and Functional Characterization of Myeloid Derived Suppressor Cell‐Like Adherent Cells

Author:

Co Soriano John Clyde1,Tsutsumi Shiho1,Ohara Daiya2,Hirota Keiji2,Kondoh Gen2,Niwa Tatsuya3,Taguchi Hideki3,Kadonosono Tetsuya1ORCID,Kizaka‐Kondoh Shinae1

Affiliation:

1. School of Life Science and Technology Tokyo Institute of Technology Yokohama 226–8501 Japan

2. Institute for Frontier Life and Medical Sciences Kyoto University Sakyo‐Ku Kyoto 606–8507 Japan

3. Institute for Innovative Research Tokyo Institute of Technology Yokohama 226–8503 Japan

Abstract

AbstractMyeloid‐derived suppressor cell (MDSC)‐like adherent cells (MLACs) are a recently identified CD11b+F4/80 myeloid cell subset that can infiltrate tumors early in development and promote their growth. Because of these functions, MLACs play an important role in establishing an immunosuppressive tumor microenvironment (TME). However, the lack of MLAC‐specific markers has hampered further characterization of this cell type. This study identifies the gene signature of MLACs by analyzing RNA‐sequencing (RNA‐seq) and public single‐cell RNA‐seq data, revealing that MLACs are an independent cell population that are distinct from other intratumoral myeloid cells. After combining proteome analysis of membrane proteins with RNA‐seq data, H2‐Ab1 and CD11c are indicated as marker proteins that can support the isolation of MLAC subsets from CD11b+F4/80 myeloid cells by fluorescence‐activated cell sorting. The CD11b+F4/80H2‐Ab1+ and CD11b+F4/80CD11c+ MLAC subsets represent approximately half of the MLAC population that is isolated based on their adhesion properties and possess gene signatures and functional properties similar to those of the MLAC population. Additionally, membrane proteome analysis suggests that MLACs express highly heterogeneous surface proteins. This study facilitates an integrated understanding of heterogeneous intratumoral myeloid cells, as well as the molecular and cellular details of the development of an immunosuppressive TME.

Funder

Naito Foundation

Princess Takamatsu Cancer Research Fund

NOVARTIS Foundation (Japan) for the Promotion of Science

Publisher

Wiley

Subject

General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3